232 related articles for article (PubMed ID: 29844172)
1. Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.
Henriques A; Koliaraki V; Kollias G
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5546-E5555. PubMed ID: 29844172
[TBL] [Abstract][Full Text] [Related]
2. Sec6 enhances cell migration and suppresses apoptosis by elevating the phosphorylation of p38 MAPK, MK2, and HSP27.
Tanaka T; Iino M; Goto K
Cell Signal; 2018 Sep; 49():1-16. PubMed ID: 29729335
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.
Nguyen Ho-Bouldoires TH; Clapéron A; Mergey M; Wendum D; Desbois-Mouthon C; Tahraoui S; Fartoux L; Chettouh H; Merabtene F; Scatton O; Gaestel M; Praz F; Housset C; Fouassier L
Free Radic Biol Med; 2015 Dec; 89():34-46. PubMed ID: 26169728
[TBL] [Abstract][Full Text] [Related]
4. Involvement of mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) in endothelial dysfunction associated with pulmonary hypertension.
Shafiq M; Lone ZR; Bharati P; Singh H; Jagavelu K; Verma NK; Ghosh JK; Gaestel M; Hanif K
Life Sci; 2021 Dec; 286():120075. PubMed ID: 34678260
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulation of TNF-induced expression of ICAM-1 and IL-8 in human lung microvascular endothelial cells: an obligatory role for the p38 MAPK-MK2 pathway dissociated with HSP27.
Su X; Ao L; Zou N; Song Y; Yang X; Cai GY; Fullerton DA; Meng X
Biochim Biophys Acta; 2008 Sep; 1783(9):1623-31. PubMed ID: 18486623
[TBL] [Abstract][Full Text] [Related]
6. MAPK-activated protein kinase-2 (MK2)-mediated formation and phosphorylation-regulated dissociation of the signal complex consisting of p38, MK2, Akt, and Hsp27.
Zheng C; Lin Z; Zhao ZJ; Yang Y; Niu H; Shen X
J Biol Chem; 2006 Dec; 281(48):37215-26. PubMed ID: 17015449
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of heat shock protein 27 antagonizes TNF-α induced HeLa cell apoptosis via regulating TAK1 ubiquitination and activation of p38 and ERK signaling.
Qi Z; Shen L; Zhou H; Jiang Y; Lan L; Luo L; Yin Z
Cell Signal; 2014 Jul; 26(7):1616-25. PubMed ID: 24686082
[TBL] [Abstract][Full Text] [Related]
8. Anthrax lethal toxin-induced lung injury and treatment by activating MK2.
Liu T; Warburton RR; Hill NS; Kayyali US
J Appl Physiol (1985); 2015 Aug; 119(4):412-9. PubMed ID: 26066827
[TBL] [Abstract][Full Text] [Related]
9. Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27.
Lin SP; Lee YT; Wang JY; Miller SA; Chiou SH; Hung MC; Hung SC
PLoS One; 2012; 7(11):e49605. PubMed ID: 23185379
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.
Gurgis FM; Ziaziaris W; Munoz L
Mol Pharmacol; 2014 Feb; 85(2):345-56. PubMed ID: 24296859
[TBL] [Abstract][Full Text] [Related]
11. SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation.
Sreekanth GP; Chuncharunee A; Sirimontaporn A; Panaampon J; Noisakran S; Yenchitsomanus PT; Limjindaporn T
PLoS One; 2016; 11(2):e0149486. PubMed ID: 26901653
[TBL] [Abstract][Full Text] [Related]
12. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.
Ray AL; Berggren KL; Restrepo Cruz S; Gan GN; Beswick EJ
Int J Cancer; 2018 Apr; 142(8):1702-1711. PubMed ID: 29197088
[TBL] [Abstract][Full Text] [Related]
14. MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.
Gorog DA; Jabr RI; Tanno M; Sarafraz N; Clark JE; Fisher SG; Cao XB; Bellahcene M; Dighe K; Kabir AM; Quinlan RA; Kato K; Gaestel M; Marber MS; Heads RJ
Cell Stress Chaperones; 2009 Sep; 14(5):477-89. PubMed ID: 19214782
[TBL] [Abstract][Full Text] [Related]
15. p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.
Menon MB; Schwermann J; Singh AK; Franz-Wachtel M; Pabst O; Seidler U; Omary MB; Kotlyarov A; Gaestel M
J Biol Chem; 2010 Oct; 285(43):33242-33251. PubMed ID: 20724476
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.
Nie X; Chanley MA; Pengal R; Thomas DB; Agrawal S; Smoyer WE
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F602-F613. PubMed ID: 29187369
[TBL] [Abstract][Full Text] [Related]
17. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
[TBL] [Abstract][Full Text] [Related]
18. MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer.
Suarez-Lopez L; Kong YW; Sriram G; Patterson JC; Rosenberg S; Morandell S; Haigis KM; Yaffe MB
Front Immunol; 2020; 11():607891. PubMed ID: 33708191
[TBL] [Abstract][Full Text] [Related]
19. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
20. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Xu L; Bergan RC
Mol Pharmacol; 2006 Sep; 70(3):869-77. PubMed ID: 16772519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
